Results 111 to 120 of about 2,325 (161)

Aptamer-Nanoconjugates as Potential Theranostics in Major Neuro-Oncological and Neurodegenerative Disorders. [PDF]

Pharmaceutics
Tauser RG, Lupascu FG, Profire BS, Iacob AT, Vasincu IM, Apotrosoaei M, Chirliu OM, Lupascu D, Profire L.   +8 more
europepmc   +1 more source

Innovative Applications of Nucleic Acid Aptamers in Colorectal Cancer Diagnosis and Therapy: From Selection Optimization to Clinical Translation. [PDF]

Int J Nanomedicine
Lu JF, Zhang XR, Liu Y, Zhang CL, Wang L, Liu ZQ, Cai J, Yi HW.   +7 more
europepmc   +1 more source

Aptamer-Based Delivery of Genes and Drugs Across the Blood-Brain Barrier. [PDF]

Pharmaceuticals (Basel)
Yang L, Yin Y, Liu X, Guo B.
europepmc   +1 more source

[Ultrasound-synergized targeted nanoparticles suppress proliferation, migration and invasion of hypoxic lung cancer cells <i>in vitro</i>]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Dong J, Guo J, Li D, DU Y.
europepmc   +1 more source

Aptamer-based applications in delivering cancer gene therapies and beyond: state of the art and the missing links to clinical translation. [PDF]

Adv Drug Deliv Rev
Coppola G, Cennamo F, Ciccone G, Ibba ML, Ruscio AD, Vito AD, Esposito CL, Catuogno S.   +7 more
europepmc   +1 more source

Aptamers targeting immune checkpoints for tumor immunotherapy: a comprehensive review. [PDF]

Front Oncol
Gedla MK, Kotla RSP, Kumar R, Kamesh V, S J, Kamalakannan D, Ramasamy J.   +6 more
europepmc   +1 more source

DNA Tweezers with Replaceable Clamps for the Targeted Degradation of Cell Membrane Proteins. [PDF]

Pharmaceutics
Sun Y, Huang Y, Chen D, Hu S, Pan T, Liu Y, Wang R, Tan W.   +7 more
europepmc   +1 more source

Aptamer as a therapeutic agent for dengue infections. [PDF]

Virol J
Mislan NAL, Marimuthu C, Akmal Shukri AM, Suppiah J, Mohd Zain R, Mohd Nor F, Wang SM.   +6 more
europepmc   +1 more source

A Modular DNAzyme for Precise Visualization and Intervention of Alternative Splicing Isoforms in Live Cells. [PDF]

Adv Sci (Weinh)
Lin M, Sun J, Mao Y, Tang Y, Wang F, Liu Z, Wang J.   +6 more
europepmc   +1 more source

Ligand-modified liposomes as drug delivery systems for the active targeting of pancreatic cancer. [PDF]

Int J Pharm X
Jang Y, Jang J, Son J, Lee HY, Choi J.
europepmc   +1 more source